Home Healthcare Biotechnology Biopharmaceutical Excipients Market

Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Excipient (Bulking Agents, Solubilizers and Surfactants, Buffering and Tonicity Agents, Others), By Biologics (Monoclonal Antibodies, Vaccines, Others), By Scale of Operation (Commercial, Research), By End-User (Pharma and Biotech Companies, CMOS and CDMOS, Academic and Research Institutes) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR3549DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Biopharmaceutical Excipients Market Size Analysis
    1. Introduction
    2. Biopharmaceutical Excipients Market Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
      1. Bulking Agents
      2. Solubilizers and Surfactants
      3. Buffering and Tonicity Agents
      4. Others
    3. Biopharmaceutical Excipients Market Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Others
    4. Biopharmaceutical Excipients Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Research
    5. Biopharmaceutical Excipients Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharma and Biotech Companies
      2. CMOS and CDMOS
      3. Academic and Research Institutes
  7. North America Biopharmaceutical Excipients Market Size Analysis
    1. Introduction
    2. Biopharmaceutical Excipients Market Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
      1. Bulking Agents
      2. Solubilizers and Surfactants
      3. Buffering and Tonicity Agents
      4. Others
    3. Biopharmaceutical Excipients Market Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Others
    4. Biopharmaceutical Excipients Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Research
    5. Biopharmaceutical Excipients Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharma and Biotech Companies
      2. CMOS and CDMOS
      3. Academic and Research Institutes
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
  8. Europe Biopharmaceutical Excipients Market Size Analysis
    1. Introduction
    2. Biopharmaceutical Excipients Market Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
      1. Bulking Agents
      2. Solubilizers and Surfactants
      3. Buffering and Tonicity Agents
      4. Others
    3. Biopharmaceutical Excipients Market Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Others
    4. Biopharmaceutical Excipients Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Research
    5. Biopharmaceutical Excipients Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharma and Biotech Companies
      2. CMOS and CDMOS
      3. Academic and Research Institutes
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    8. France
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
  9. APAC Biopharmaceutical Excipients Market Size Analysis
    1. Introduction
    2. Biopharmaceutical Excipients Market Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
      1. Bulking Agents
      2. Solubilizers and Surfactants
      3. Buffering and Tonicity Agents
      4. Others
    3. Biopharmaceutical Excipients Market Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Others
    4. Biopharmaceutical Excipients Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Research
    5. Biopharmaceutical Excipients Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharma and Biotech Companies
      2. CMOS and CDMOS
      3. Academic and Research Institutes
    6. China
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    9. India
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
  10. Middle East and Africa Biopharmaceutical Excipients Market Size Analysis
    1. Introduction
    2. Biopharmaceutical Excipients Market Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
      1. Bulking Agents
      2. Solubilizers and Surfactants
      3. Buffering and Tonicity Agents
      4. Others
    3. Biopharmaceutical Excipients Market Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Others
    4. Biopharmaceutical Excipients Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Research
    5. Biopharmaceutical Excipients Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharma and Biotech Companies
      2. CMOS and CDMOS
      3. Academic and Research Institutes
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
  11. LATAM Biopharmaceutical Excipients Market Size Analysis
    1. Introduction
    2. Biopharmaceutical Excipients Market Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
      1. Bulking Agents
      2. Solubilizers and Surfactants
      3. Buffering and Tonicity Agents
      4. Others
    3. Biopharmaceutical Excipients Market Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Vaccines
      3. Others
    4. Biopharmaceutical Excipients Market Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
      1. Commercial
      2. Research
    5. Biopharmaceutical Excipients Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharma and Biotech Companies
      2. CMOS and CDMOS
      3. Academic and Research Institutes
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      3. Market Size & Forecast By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      4. Market Size & Forecast By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
  12. Competitive Landscape
    1. Biopharmaceutical Excipients Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Merck KGAA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. BASF SE
    3. Avantor
    4. Evonik Industries
    5. Roquette Freres
    6. Aceto
    7. Angus Chemical
    8. Apothecon
    9. Ashland Global
    10. BioSpectra
    11. BOC Sciences
    12. C.G. Group
    13. Clariant
    14. Colorcon
    15. DFE Pharma
    16. DOW
    17. Eastman Chemical
    18. IMCD N.V.
    19. Innophos
    20. Invitria
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.